Ultroid® Technologies, Inc. Retains Armor Capital Management for Advisory Role

Sigue a El Diario NY en Facebook

TAMPA, Fla.–(BUSINESS WIRE)–Ultroid® Technologies, Inc. announces today it has
retained Armor Capital Management, Inc. Armor Capital will provide M&A
advisory services on all aspects of acquisitions, sales/divestitures,
private equity transactions and finance raising, as Ultroid® Technologies,
Inc.
expands its operations simultaneously throughout the United
States and Global markets. Its flagship product is the Ultroid®
Hemorrhoid Management System
, a non-invasive, painless, and low cost
treatment alternative. This novel treatment for Hemorrhoidal Disease
(HD) is applicable, and FDA approved, for all four grades of
internal hemorrhoids. The Ultroid® System has been effective in
over 150,000 procedures to date with no reported complications. The
system provides a safe and effective alternative to surgery for the
millions of people suffering from hemorrhoid disease and the painful
symptoms of (HD). Physicians perform the non-invasive, 15 minute
procedures in their office, without anesthesia, and experience
exceptional patient outcomes. This is a permanent alternative to
ineffective topical creams or the painful downtime and recovery of
hemorrhoid surgeries. The Ultroid® System is a quick, easy,
painless, and proven solution that requires no preparation, with most
people returning to their usual daily activities immediately after the
treatment. No negative side effects have been reported.

About Ultroid® Technologies, Inc.:

Ultroid® Technologies, Inc. is a leader in non-invasive, low
cost, micro current technologies in the United States and around the
world. The Ultroid ® System replaces over-the-counter
creams and painful surgeries by providing a quick, painless, and
permanent solution to (HD)without interrupting daily activities.

The Company’s website is http://www.Ultroid.com.
The brand names referenced in this press release are trademarks of Ultroid®
Technologies, Inc. its affiliated companies, customers, or other
third parties. The company markets and manufactures the Ultroid® Hemorrhoid
Management System
.

About Armor Capital Management

Armor Capital Management is a private equity firm that invests in
exceptional companies that meet their strict financial, and strategic
parameters. Armor Capital makes long term investments with the goal of
increasing financial performance, thus creating value for the entire
ecosystem of customers, employees, stockholders, and communities.

Safe Harbor Statements

This report includes “forward-looking statements” within the
meaning of Section 27A of the Securities Act of 1933, as amended, and
Section 21E of the Securities Exchange Act of 1934, reflecting
management’s current expectations regarding future results of
operations, economic performance, financial condition and achievements
of the Company. The forward-looking statements are based on the
assumption that operating performance will continue to exponentially
grow in line with recent trends and consistent with distribution
expansion. Management believes these assumptions to be reasonable but
there is no assurance that they will prove to be accurate.
Forward-looking statements, specifically those concerning future
performance are subject to certain risks and uncertainties, and actual
results may differ materially. These risks and uncertainties are
detailed from time to time in the Company’s filings. The Company
undertakes no obligation to publicly update or revise any
forward-looking statements.

Contacts

Ultroid® Technologies, Inc.
Michael Knox, 727-898-0717
Chief
Executive Officer
info@ultroid.com
or
Armor
Capital Management Inc.
Mat Khokhar, 407-924-1548
Partner
info@armorcapitalmtg.com